In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Both juices can help you get more antioxidants in your diet. Orange juice contains significant amounts of vitamin C and ...

The deal with a company owned by Embraer gives Beta Technologies an additional source of revenue as it develops its own electric aircraft. By Niraj Chokshi Two companies racing to develop electric ...

The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that ...

Dr Punam has issued a warning to anyone taking certain medications for heart problems or poor circulation. Speaking on today's (Nov 4) episode of the BBC's talk show Morning Live, the NHS GP urged ...

In a change of pace, one company operating in the aerospace sector is expected to make its market debut today. Here’s what you need to know about Beta Technologies and its initial public offering: ...

Read Seven Days’ November 5, 2025, cover story on Beta here. Vermont electric aviation startup Beta Technologies raked in more than $1 billion on Tuesday as it debuted on the New York Stock Exchange ...

(Reuters) -Electric aircraft maker Beta Technologies is expected to price its initial public offering at $34 per share, which is above its marketed range, Bloomberg News reported on Monday, citing ...

BETA Technologies, Inc. (BETA) has filed to raise $100 million in an IPO of its Class A common stock, according to SEC S-1 registration information. BETA is developing all-electric airplanes and ...

Apple has just released the first public betas for iOS 26.1 and more. Here’s what’s new in iOS 26.1 public beta 1. New features and changes in iOS 26.1 beta 1 iOS 26.1 is the next big update coming ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...